The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Marwan G. Fakih

GI Oncology

Department of Medicine

Roswell Park Cancer Institute

Elm and Carlton streets



Name/email consistency: high



  • GI Oncology, Department of Medicine, Roswell Park Cancer Institute, Elm and Carlton streets, U.S.A. 2004 - 2011
  • Department of Medicine, University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, New York 14263, USA. 2010


  1. First-line Cisplatin Plus Etoposide in High-grade Metastatic Neuroendocrine Tumors of Colon and Rectum (MCRC NET): Review of 8 Cases. Patta, A., Fakih, M. Anticancer Res. (2011) [Pubmed]
  2. Making sense of anti-EGFR plus oxaliplatin-based therapy in the first-line treatment of metastatic colorectal cancer. Fakih, M.G. Future. Oncol (2011) [Pubmed]
  3. A phase I, pharmacokinetic, and pharmacodynamic study of two schedules of vorinostat in combination with 5-fluorouracil and leucovorin in patients with refractory solid tumors. Fakih, M.G., Fetterly, G., Egorin, M.J., Muindi, J.R., Espinoza-Delgado, I., Zwiebel, J.A., Litwin, A., Holleran, J.L., Wang, K., Diasio, R.B. Clin. Cancer Res. (2010) [Pubmed]
  4. KRAS mutation screening in colorectal cancer: From paper to practice. Fakih, M.M. Clin. Colorectal. Cancer (2010) [Pubmed]
  5. Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer. Fakih, M.G., Trump, D.L., Johnson, C.S., Tian, L., Muindi, J., Sunga, A.Y. Int. J. Colorectal. Dis (2009) [Pubmed]
  6. Does celecoxib have a role in the treatment of patients with colorectal cancer? Fakih, M.G., Rustum, Y.M. Clin. Colorectal. Cancer (2009) [Pubmed]
  7. A phase I, pharmacokinetic and pharmacodynamic study on vorinostat in combination with 5-fluorouracil, leucovorin, and oxaliplatin in patients with refractory colorectal cancer. Fakih, M.G., Pendyala, L., Fetterly, G., Toth, K., Zwiebel, J.A., Espinoza-Delgado, I., Litwin, A., Rustum, Y.M., Ross, M.E., Holleran, J.L., Egorin, M.J. Clin. Cancer Res. (2009) [Pubmed]
  8. A Phase I and pharmacokinetic study of selenomethionine in combination with a fixed dose of irinotecan in solid tumors. Fakih, M.G., Pendyala, L., Brady, W., Smith, P.F., Ross, M.E., Creaven, P.J., Badmaev, V., Prey, J.D., Rustum, Y.M. Cancer Chemother. Pharmacol. (2008) [Pubmed]
  9. The role of targeted therapy in the treatment of advanced colorectal cancer. Fakih, M. Curr. Treat. Options. Oncol (2008) [Pubmed]
  10. Management of anti-EGFR-targeting monoclonal antibody-induced hypomagnesemia. Fakih, M. Oncology (Williston Park, N.Y.) (2008) [Pubmed]
  11. Anti-EGFR monoclonal antibodies in metastatic colorectal cancer: time for an individualized approach?. Fakih, M. Expert. Rev. Anticancer. Ther (2008) [Pubmed]
  12. Increased frequency of uridine diphosphate glucuronosyltransferase 1A1 7/7 in patients experiencing severe irinotecan-induced toxicities. Fakih, M.G., Ross, M.E., Starostik, P. Clin. Colorectal. Cancer (2007) [Pubmed]
  13. A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors. Fakih, M.G., Trump, D.L., Muindi, J.R., Black, J.D., Bernardi, R.J., Creaven, P.J., Schwartz, J., Brattain, M.G., Hutson, A., French, R., Johnson, C.S. Clin. Cancer Res. (2007) [Pubmed]
  14. A phase I and pharmacokinetic study of fixed-dose selenomethionine and irinotecan in solid tumors. Fakih, M.G., Pendyala, L., Smith, P.F., Creaven, P.J., Reid, M.E., Badmaev, V., Azrak, R.G., Prey, J.D., Lawrence, D., Rustum, Y.M. Clin. Cancer Res. (2006) [Pubmed]
  15. Gemcitabine-induced rectus abdominus radiation recall. Fakih, M.G. JOP (2006) [Pubmed]
  16. A Phase I study of weekly intravenous oxaliplatin in combination with oral daily capecitabine and radiation therapy in the neoadjuvant treatment of rectal adenocarcinoma. Fakih, M.G., Rajput, A., Yang, G.Y., Pendyala, L., Toth, K., Smith, J.L., Lawrence, D.D., Rustum, Y.M. Int. J. Radiat. Oncol. Biol. Phys. (2006) [Pubmed]
  17. CEA monitoring in colorectal cancer. What you should know. Fakih, M.G., Padmanabhan, A. Oncology (Williston Park, N.Y.) (2006) [Pubmed]
  18. Cetuximab-induced hypomagnesemia in patients with colorectal cancer. Fakih, M.G., Wilding, G., Lombardo, J. Clin. Colorectal. Cancer (2006) [Pubmed]
  19. Phase I and pharmacokinetic study of weekly docetaxel, cisplatin, and daily capecitabine in patients with advanced solid tumors. Fakih, M.G., Creaven, P.J., Ramnath, N., Trump, D., Javle, M., Strychor, S., Repinski, T.V., Zamboni, B.A., Schwarz, J.K., French, R.A., Zamboni, W.C. Clin. Cancer Res. (2005) [Pubmed]
  20. 5-fluorouracil leucovorin and oxaliplatin (FOLFOX) in the treatment of metastatic colon cancer with severe liver dysfunction. Fakih, M.G. Oncology (2004) [Pubmed]
WikiGenes - Universities